Related references
Note: Only part of the references are listed.Use of Conventional, Complementary, and Alternative Treatments for Pain Among Individuals Seeking Primary Care Treatment With Buprenorphine-Naloxone
Declan T. Barry et al.
JOURNAL OF ADDICTION MEDICINE (2012)
Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review
Sebastiano Mercadante et al.
PALLIATIVE MEDICINE (2011)
Role of key informants and direct patient interviews in epidemiological studies of substance abuse
Theodore J. Cicero et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Prescription Drug Abuse: Epidemiology, Regulatory Issues, Chronic Pain Management with Narcotic Analgesics
Jeanne M. Manubay et al.
PRIMARY CARE (2011)
Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies
William W. Stoops et al.
PSYCHOPHARMACOLOGY (2010)
Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007
Michael F. Schneider et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Blood-brain-barrier tran-port helps to explain discrepancies in in vivo potency between oxycodone and morphine
Emma Bostrom et al.
ANESTHESIOLOGY (2008)
Buprenorphine - New tricks with an old molecule for pain management
Howard A. Heit et al.
CLINICAL JOURNAL OF PAIN (2008)
Abuse liability of prescription opioids compared to heroin in morphine-maintained heroin abusers
Sandra D. Comer et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers
James P. Zacny et al.
PSYCHOPHARMACOLOGY (2008)
Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers
SD Comer et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans
SD Comer et al.
PSYCHOPHARMACOLOGY (2001)
Share Paper
